Biocryst Pharmaceuticals (BCRX) Change in Account Payables: 2014-2015
Historic Change in Account Payables for Biocryst Pharmaceuticals (BCRX) over the last 1 years, with Dec 2015 value amounting to $1.1 million.
- Biocryst Pharmaceuticals' Change in Account Payables rose 3.80% to $1.1 million in Q4 2015 from the same period last year, while for Dec 2015 it was $13.7 million, marking a year-over-year change of. This contributed to the annual value of -$62.4 million for FY2024, which is 271.17% down from last year.
- Latest data reveals that Biocryst Pharmaceuticals reported Change in Account Payables of $1.1 million as of Q4 2015, which was down 72.44% from $4.0 million recorded in Q3 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Change in Account Payables peaked at $5.2 million during Q2 2015, and registered a low of $1.1 million during Q4 2014.
- In the last 2 years, Biocryst Pharmaceuticals' Change in Account Payables had a median value of $3.6 million in 2014 and averaged $3.1 million.
- Data for Biocryst Pharmaceuticals' Change in Account Payables shows a peak YoY rose of 3.80% (in 2015) over the last 5 years.
- Biocryst Pharmaceuticals' Change in Account Payables (Quarterly) stood at $1.1 million in 2014, then increased by 3.80% to $1.1 million in 2015.
- Its last three reported values are $1.1 million in Q4 2015, $4.0 million for Q3 2015, and $5.2 million during Q2 2015.